Meet Melanoma survivor TJ Sharpe in the first installment of his new blog series on Novartis.com.

Novartis is developing an experimental drug for weight loss.

Novartis researchers leverage in-house startup initiative to begin digital technology research collaboration.

Novartis researchers are using data to accelerate drug development.

People with breast cancer need better medicines that help reduce the risk and anxiety of it returning.

Novartis has launched a comprehensive research program to help find the right combinations of therapies for the right patients.

Improving the patient experience and removing potential barriers to clinical trial participation

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.